PARVOVIRUS B19 INFECTION

This adverse event was reported 895 times

PARVOVIRUS B19 INFECTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TREOSULFAN 40 0.0145
1 BASILIXIMAB 120 0.0101
2 ANTI-THYMOCYTE GLOBULIN (RABBIT) 53 0.0065
3 CIDOFOVIR ANHYDROUS 9 0.0062
4 DEFEROXAMINE MESYLATE 13 0.0060
5 GANCICLOVIR SODIUM 49 0.0046
6 TACROLIMUS EXTENDED-RELEASE CAPSULES 530 0.0042
7 TACROLIMUS OINTMENT 0.1% 528 0.0041
8 THIOTEPA 40 0.0041
9 MYCOPHENILIC ACID 80 0.0037
See all drugs enriched for association with PARVOVIRUS B19 INFECTION